The future of breast cancer screening in Australia is set to undergo a significant transformation, shifting from a one-size-fits-all approach to a more personalized and targeted strategy. This shift is driven by the recognition that breast cancer risk is multifaceted, influenced by factors such as breast density, family history, genetic predispositions, and potentially, artificial intelligence (AI). The upcoming changes to the BreastScreen program aim to revolutionize how women are screened, moving away from age-based guidelines towards a more nuanced, risk-based approach.
The Rise of Risk-Stratified Screening
Risk-stratified screening is a personalized approach that tailors the type and frequency of imaging based on an individual's risk profile. This method is designed to detect cancer early and improve outcomes, ensuring that resources are directed where they are most needed. Currently, BreastScreen programs primarily recommend annual screenings for women with a significant family history of breast and/or ovarian cancer, a limitation that has hindered the effective management of individual risks.
Unlocking the Power of Breast Density
Breast density, a well-established risk factor, is a critical component of this new paradigm. Women with dense breasts, characterized by white areas on mammograms representing fibroglandular tissue, face a heightened risk of developing breast cancer and of cancer going undetected during screenings. BreastScreen Australia has taken proactive steps by recommending that all women be informed of their breast density at the time of screening and providing guidance for GPs when consulting women with dense breasts.
However, the challenge lies in effectively communicating risk to women with dense breasts and ensuring their access to additional imaging techniques, such as 3D mammography, contrast-enhanced mammography, and MRI, if available. This communication gap and the accessibility of advanced imaging methods require further exploration to ensure women receive the necessary support and information.
Family History, Genetic Tests, and the Role of AI
Online risk assessment tools, such as iPrevent and CanRisk, play a pivotal role in this new landscape. These tools integrate breast density with other risk factors, including family history and genetic test results, to calculate an individual's risk. Genetic tests can provide valuable insights, with the presence of multiple gene variants contributing to a polygenic risk score, enabling the identification of younger women at increased risk who could benefit from earlier screening.
AI is another game-changer, offering the potential to interpret mammography imaging more accurately and predict future disease risk. By reducing radiologists' workloads and identifying individuals requiring further assessment, AI can significantly enhance the efficiency and effectiveness of breast cancer screening.
Navigating the Unknown Pathways
Despite the promise of these advancements, significant challenges remain. The pathways to obtain and utilize risk information have yet to be fully developed, requiring the adoption of the latest risk prediction methods and screening technologies. Collaboration with consumers and stakeholders is essential to co-design clear and consistent pathways for managing individuals in different risk categories.
Pilot studies are crucial to testing the acceptability and feasibility of these pathways before large-scale implementation. Effective communication of individual risk to women and their health professionals is another critical aspect that needs to be addressed. These processes are expected to unfold in stages over the next decade, ensuring a gradual and well-informed transition.
Moving Forward: A Personalized Approach
In the meantime, women are advised to continue with their regular mammograms as scheduled through BreastScreen Australia. Women over 40 are eligible for free mammograms every two years, while those aged 50-74 are invited to screen. Regular consultations with doctors about breast health and prompt attention to any new symptoms are also recommended.
The upcoming changes to breast cancer screening in Australia represent a significant step towards a more personalized and effective approach. By embracing risk-stratified screening, leveraging breast density, and harnessing the power of AI, the country is poised to make substantial strides in early detection and improved outcomes for women at risk of breast cancer.
